Presentation TCT 2013 Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial Presenter: Gregg Stone October 27, 2013
Presentation TCT 2013 LAA Closure is Now Established - The Added Value of New Randomized Trials Would be Minimal! Presenter: Matthew Price October 27, 2013
Presentation TCT 2013 Emerging Technologies for CLI: Advantages to Working Together Presenter: Hiroyoshi Yokoi October 27, 2013
Presentation TCT 2013 MHLW/PMDA Perspectives on HBD: Past, Present, and Future Presenter: Nobuhiro Handa October 27, 2013
Presentation TCT 2013 Hemodynamics and Interactive Calculations for Aortic Stenosis using the “John Madden” Telestrator Presenter: Jeff Davis October 27, 2013
Presentation TCT 2013 Latest Results from ABSORB Extend: Comparison with Xience Presenter: Bernard Chevalier October 27, 2013
Presentation TCT 2013 Chemical Ablation for Renal Denervation (Northwind Technologies) Presenter: Mark Wholey October 27, 2013
Presentation TCT 2013 Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR Presenter: Neil Moat October 27, 2013
Presentation TCT 2013 No: In Fact, the Lack of Control Will Lead to Unpredictable Safety and Efficacy Outcomes! Presenter: Jochen W?hrle October 27, 2013